BioCryst Pharmaceuticals, Inc

(NASDAQ:BCRX)

Latest On BioCryst Pharmaceuticals, Inc (BCRX):

Date/Time Type Description Signal Details
2023-05-31 17:21 ESTNewsBioCryst Pharmaceuticals: An Updated ViewN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 21:24 ESTNewsBioCryst gains 14% most since February after Q1 2023 resultsN/A
2023-05-03 08:06 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.28 beats by $0.03, revenue of $68.78M misses by $2.66MN/A
2023-04-18 20:53 ESTNewsBioCryst secures five-year credit facilityN/A
2023-04-12 14:45 ESTNewsThe Big Short: 5 Stocks At Risk With High Short InterestN/A
2023-03-17 06:01 ESTNewsBioCryst's Commercialization Of Orladeyo: Risks Materializing, A Shorting OpportunityN/A
2023-03-08 22:50 ESTNewsBioCryst: Good Candidate For Buyout, But Not For Anything ElseN/A
2023-03-08 22:50 ESTNewsBioCryst wins Canadian nod for Orladeyo reimbursementN/A
2023-03-02 13:37 ESTNewsBioCryst Pharmaceuticals (BCRX) Presents At J.P. MORGAN HEALTHCARE CONFERENCEN/A
2023-02-22 23:25 ESTNewsBioCryst adds 13% to rebound as Needham upgrades; says selloff overdoneN/A
2023-02-22 10:26 ESTNewsBioCryst Is Not Currently Uncovering The Full Value Of ORLADEYON/A
2023-02-21 21:57 ESTNewsBioCryst at nine-month low as Q4 bottom-line disappointsN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call TranscriptN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-21 08:13 ESTNewsBioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32MN/A
2023-02-20 19:27 ESTNewsBioCryst Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-04 07:22 ESTNewsBioCryst Pharmaceuticals: An Overview Of Orladeyo For Hereditary AngioedemaN/A
2023-01-23 12:51 ESTNewsBioCryst teams up with Swixx to sell Orladeyo in Central, Eastern EuropeN/A
2023-01-09 13:46 ESTNewsBioCryst drops as sales for hereditary angioedema therapy lag forecastsN/A
2022-12-21 02:03 ESTNewsBioCryst Pharmaceuticals: More Aggressive Growth For OrladeyoN/A
2022-12-16 00:24 ESTNewsBioCryst drops on plans to discontinue oral Factor D inhibitorN/A
2022-12-16 00:22 ESTNewsBioCryst strategic interest likely to rise after oral Factor D inhibitor decision - CowenN/A
2022-12-06 15:56 ESTNewsBad flu season turned even worse around Thanksgiving - CDCN/A
2022-11-15 15:48 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation -SlideshowN/A
2022-11-04 16:23 ESTNewsFewer Americans have received the flu shot compared to same time last year - CDCN/A
2022-11-02 13:59 ESTNewsBioCryst rebounds as Evercore ISI upgrades after earnings day selloffN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals reports Q3 earnings beat; updates FY22 guidanceN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:52 ESTNewsBioCryst falls 11% despite Q3 beat (update)N/A
2022-10-28 13:05 ESTNewsFlu season off to a strong and early start, CDC data findsN/A
2022-10-11 12:49 ESTNewsBioCryst Pharmaceuticals: Working To Increase Market Presence Of OrladeyoN/A
2022-09-14 19:02 ESTNewsBioCryst Pharmaceuticals promotes Sheridan to development chiefN/A
2022-08-31 10:00 ESTNewsBioCryst wins FDA’s Orphan Drug status for bone disorder therapyN/A
2022-08-26 17:59 ESTNewsBioCryst's BCX9930 for rare kidney disorder shows promise in early-stage studyN/A
2022-08-25 09:20 ESTNewsBioCryst to supply 10K doses of influenza drug Rapivab to US for ~$7MN/A
2022-08-18 07:38 ESTNewsBioCryst Orladeyo gets approval in Saudi Arabia to prevent hereditary angioedema attacksN/A
2022-08-04 23:49 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:49 ESTNewsBioCryst adds 16% as FDA lifts clinical hold on kidney disease programN/A
2022-08-04 23:48 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call TranscriptN/A
2022-08-04 08:14 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.32 beats by $0.03, revenue of $65.53M beats by $1.7MN/A
2022-08-03 17:46 ESTNewsBioCryst Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-26 00:41 ESTNewsBioCryst Pharmaceuticals: Waiting For ClarityN/A
2022-06-24 22:18 ESTNewsBioCryst: A Prudent DiversificationN/A
2022-06-19 14:18 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation - SlideshowN/A
2022-06-10 13:01 ESTNewsBioCryst collaborates with Pint Pharma to sell Orladeyo in Latin AmericaN/A
2022-06-08 15:55 ESTNewsBioCryst nabs FDA’s Fast Track status for candidate targeting rare bone forming disorderN/A
2022-06-08 00:50 ESTNewsBioCryst Orladeyo gets approval in Switzerland to prevent hereditary angioedema attacksN/A

About BioCryst Pharmaceuticals, Inc (BCRX):

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BCRX Quotes by TradingView

See Advanced Chart

General

  • Name BioCryst Pharmaceuticals, Inc
  • Symbol BCRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 246
  • Fiscal Year EndDecember
  • IPO Date1994-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biocryst.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 31.41
  • Price/Book (Most Recent Quarter) 56.59
  • Enterprise Value Revenue 103.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$0.73
  • Next Quarter EPS Estimate -$0.28
  • Operating Margin -981%
  • Return on Assets -43%
  • Return on Equity -1925%
  • Revenue 17.81 million
  • Earnings Per Share -$1.15
  • Revenue Per Share $0.11
  • Gross Profit -106828000
  • Quarterly Earnings Growth -89.9%
View More

Highlights

  • Market Capitalization 2.25 billion
  • EBITDA -106253000
  • PE Ratio -12.32
  • PEG Ratio -0.28
  • Analyst Target Price $13.78
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 177.52 million
  • Shares Float 162.86 million
  • % Held by Insiders 85%
  • % Held by Institutions 73.95%
  • Shares Short 28.92 million
  • Shares Short Prior Month 28.86 million
  • Short Ratio 3.27
  • Short % of Float 18%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 2.82
  • 52 Week High $13.93
  • 52 Week Low $1.78
  • 50 Day Moving Average 11.07
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BioCryst Pharmaceuticals, Inc (BCRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BioCryst Pharmaceuticals, Inc (BCRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.34-$0.24-42.56%
2020-09-302020-11-05$N/A-$0.26-$0.26-1.13%
2020-06-302020-08-06$N/A-$0.24-$0.254.53%
2020-03-312020-05-06$N/A-$0.24-$0.240.62%
2019-12-312020-03-05$39.73 million-$0.02-$0.2792.51%
2019-09-302019-11-06$1.78 million-$0.34-$0.31-8.11%
2019-06-302019-08-06$1.45 million-$0.34-$0.32-7.12%
2019-03-312019-05-08$5.89 million-$0.28-$0.28-1.82%
2018-12-312019-03-04$2.73 million-$0.25-$0.24-2.75%
2018-09-302018-11-06$1.45 million-$0.28-$0.26-7.94%
2018-06-302018-08-07$12.49 million-$0.19-$0.2421.26%
2018-03-312018-05-08$3.98 million-$0.26-$0.19-35.06%
2017-12-312018-02-27$3.89 million-$0.20-$0.16-26.5%
2017-09-302017-11-07$8.76 million-$0.18-$0.182.39%
2017-06-302017-08-07$3.1 million-$0.21-$0.19-10.53%
2017-03-312017-05-04$9.44 million-$0.19-$0.19-2.15%
2016-12-312017-02-27$8.98 million-$0.06-$0.2474.82%
2016-09-302016-11-07$7.76 million-$0.16-$0.2637.84%
2016-06-302016-08-04$4.79 million-$0.22-$0.2615.25%
2016-03-312016-05-05$4.82 million-$0.31-$0.23-34.32%
2015-12-312016-02-23$4.6 million-$0.25-$0.250.68%
2015-09-302015-11-05$10.99 million-$0.20-$0.200%
2015-06-302015-08-07$25.84 million$0.06-$0.22127.27%
2015-03-312015-05-08$6.83 million-$0.21-$0.2516%
2014-12-312015-02-18$5.45 million-$0.16-$0.2123.81%
2014-09-302014-11-06$3.24 million-$0.12-$0.2040%
2014-06-302014-08-05$1.47 million-$0.23-$0.19-21.05%
2014-03-312014-05-08$3.46 million-$0.17-$0.170%
2013-12-312014-02-26$10.57 million-$0.09-$0.090%
2013-09-302013-11-05$2.39 million-$0.14-$0.11-27.27%
2013-06-302013-08-08$821000-$0.23-$0.13-76.92%
2013-03-312013-05-07$3.55 million-$0.09-$0.1540%
2012-12-312013-02-19$4.1 million-$0.18-$0.16-12.5%
2012-09-302012-11-08$5.76 million-$0.19-$0.2524%
2012-06-302012-08-02$4.21 million-$0.25-$0.263.85%
2012-03-312012-05-07$12.22 million-$0.13-$0.2650%
2011-12-312012-02-16$5.22 million-$0.29-$0.28-3.57%
2011-09-302011-11-02$5.25 million-$0.32-$0.26-23.08%
2011-06-302011-08-04$3.74 million-$0.36-$0.25-44%
2011-03-312011-05-04$5.44 million-$0.29-$0.20-45%
2010-12-312011-02-10$16.69 million-$0.20-$0.214.76%
2010-09-302010-10-28$12 million-$0.24-$0.17-41.18%
2010-06-302010-08-05$7.62 million-$0.23-$0.22-4.55%
2010-03-312010-04-28$26.07 million-$0.06-$0.1662.5%
2009-12-312010-02-04$54.9 million$0.35$0.09288.89%
2009-09-302009-10-29$10.55 million-$0.28-$0.22-27.27%
2009-06-302009-07-30$4.79 million-$0.23-$0.258%
2009-03-312009-05-08$4.36 million-$0.24-$0.2814.29%
2008-12-312009-02-06$34.24 million$0.26-$0.22218.18%
2008-09-302008-10-31$8.89 million-$0.24-$0.240%
2008-06-302008-08-07$2.66 million-$0.33-$0.20-65%
2008-03-312008-05-08$10.77 million-$0.34-$0.18-88.89%
2007-12-312008-03-04$28.17 million-$0.06-$0.3984.62%
2007-09-302007-11-08$20.46 million-$0.32-$0.28-14.29%
2007-06-302007-08-09$13.44 million-$0.24-$0.3327.27%
2007-03-312007-05-09$9.16 million-$0.30-$0.27-11.11%
2006-12-312007-02-07$2.09 million-$0.34-$0.5032%
2006-09-302006-11-08$1.79 million-$0.53-$0.41-29.27%
2006-06-302006-08-09$1.56 million-$0.35-$0.29-20.69%
2006-03-312006-04-27$771000-$0.27-$0.24-12.5%
2005-12-312006-02-08$21000-$0.27-$0.296.9%
2005-09-302005-10-26$32000-$0.29-$0.24-20.83%
2005-06-302005-08-03$58000-$0.22-$0.2512%
2005-03-312005-04-21$41000-$0.24-$0.240%
2004-12-312005-02-02$178000-$0.24-$0.267.69%
2004-09-302004-10-20$116000-$0.24-$0.240%
2004-06-302004-07-21$43000-$0.23-$0.2817.86%
2004-03-312004-04-21$N/A-$0.28-$0.22-27.27%
2003-12-312004-02-04$654000-$0.18-$0.2010%
2003-09-302003-10-20$N/A-$0.19
2003-06-302003-07-30$N/A-$0.18
2003-03-312003-03-31$N/A-$0.16
2002-12-312002-12-31$N/A-$0.16
2002-09-302002-09-30$N/A-$0.19
2002-06-302002-06-30$N/A-$0.29
2002-03-312002-03-31$N/A-$0.32
2001-12-312002-01-30$4.34 million-$0.28-$0.14-100%
2001-09-302001-10-24$3.4 million$0.02-$0.13115.38%
2001-06-302001-07-25$3.64 million-$0.08-$0.1233.33%
2001-03-312001-04-25$703000-$0.08-$0.1127.27%
2000-12-312001-02-01$803000-$0.11-$0.128.33%
2000-09-302000-10-25$763000-$0.09-$0.1118.18%
2000-06-302000-07-26$1.19 million-$0.11-$0.128.33%
2000-03-312000-04-26$564000$0.10-$0.04350%
1999-12-312000-02-02-$0.03-$0.01-200%
1999-09-301999-10-21-$0.15-$0.1816.67%
1999-06-301999-07-21-$0.02-$0.0875%
1999-03-311999-03-31-$0.16
1998-12-311999-01-27-$0.10-$0.2458.33%
1998-09-301998-10-28$0.19$0.185.56%
1998-06-301998-07-22-$0.21-$0.2516%
1998-03-311998-03-31-$0.22
1997-12-311998-02-03-$0.21-$0.238.7%
1997-03-311997-04-28-$0.23-$0.12-91.67%
1996-12-311997-02-10-$0.15-$0.2128.57%
1996-09-301996-10-29-$0.23-$0.2817.86%
1996-06-301996-07-25-$0.11$0.05-320%
1996-03-311996-04-24-$0.20-$0.2623.08%
1995-12-311996-01-29-$0.23-$0.2611.54%
1995-09-301995-10-17-$0.20-$0.2313.04%
1995-06-301995-07-25-$0.18-$0.3345.45%
1995-03-311995-04-28-$0.37-$0.31-19.35%
1994-12-311995-01-31-$0.24-$0.267.69%
1994-09-301994-10-26-$0.22-$0.3129.03%
1994-06-301994-08-02-$0.25-$0.3324.24%

BioCryst Pharmaceuticals, Inc (BCRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BioCryst Pharmaceuticals, Inc (BCRX) Chart:

BioCryst Pharmaceuticals, Inc (BCRX) News:

Below you will find a list of latest news for BioCryst Pharmaceuticals, Inc (BCRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BioCryst Pharmaceuticals, Inc (BCRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-177.56.5CALL 10.03TRUE00
2026-07-1712.50.85CALL2 180.25FALSE00
2026-06-1817.8CALL6 11703.49TRUE7.80
2026-06-1826.85CALL1 0467.31TRUE6.850
2026-06-1835.73CALL0 1426.8TRUE00
2026-06-1844.21CALL0 8303.86TRUE00
2026-06-1853.31CALL0 79212.06TRUE00
2026-06-1862.2CALL0 42168.19TRUE00
2026-06-1872.05CALL0 1605129.75TRUE00
2026-06-1880.95CALL50 101578.78TRUE0.950
2026-06-1890.55CALL2024 410287.73FALSE-0.04-0.07
2026-06-18100.3CALL162 2472499.06FALSE-0.05-0.14
2026-06-18110.2CALL3 11168109.92FALSE0.20
2026-06-18120.15CALL1 5732205.37FALSE0.150
2026-06-18130.15CALL0 2138147.41FALSE00
2026-06-18140.07CALL0 614149.88FALSE00
2026-06-18150.2CALL1 773206.51FALSE0.11
2026-06-18160.05CALL0 6156.49FALSE00
2026-06-18170CALL0 0301.69FALSE00
2026-06-18180CALL0 0178.96FALSE00
2026-06-1810.03PUT6 14501.86FALSE0.030
2026-06-1820.03PUT1 0339FALSE0.030
2026-06-1830.18PUT0 4248.55FALSE00
2026-06-1840.35PUT0 1508.68FALSE00
2026-06-1850PUT0 0315.93FALSE00
2026-06-1860.05PUT775 2540110.67FALSE0.050
2026-06-1870.1PUT10 59579.17FALSE0.051
2026-06-1880.19PUT0 399447.69FALSE00
2026-06-1890.85PUT291 647168.19TRUE0.20.31
2026-06-18101.3PUT0 90878.86TRUE00
2026-06-18112.05PUT0 10070.11TRUE00
2026-06-18120PUT0 60TRUE00
2026-06-18134.03PUT0 70TRUE00
2026-06-18144.94PUT0 00TRUE00
2026-06-18150PUT0 00TRUE00
2026-06-18160PUT0 00TRUE00
2026-06-18170PUT0 00TRUE00
2026-06-18180PUT0 00TRUE00
2026-07-1718CALL0 1425.7TRUE00
2026-07-1726.5CALL0 0281.32TRUE00
2026-07-1730CALL0 0224.68TRUE00
2026-07-1740CALL0 0182.29TRUE00
2026-07-1750CALL0 097.83TRUE00
2026-07-1760CALL0 0119.28TRUE00
2026-07-1772.45CALL0 1113.6TRUE00
2026-07-1781.35CALL1 1125.03TRUE1.350
2026-07-1791CALL0 2987.62FALSE00
2026-07-17100.5CALL228 23597.8FALSE-0.05-0.09
2026-07-17110.43CALL3 1319100.44FALSE0.430
2026-07-17120.25CALL0 96993.23FALSE00
2026-07-17130.4CALL0 76100.01FALSE00
2026-07-17140CALL0 0200.15FALSE00
2026-07-17150.1CALL0 42099.89FALSE00
2026-07-17160CALL0 0173.49FALSE00
2026-07-17170CALL0 0182.94FALSE00
2026-07-1710.05PUT0 1425.32FALSE00
2026-07-1720PUT0 0420.22FALSE00
2026-07-1730.05PUT0 1308.08FALSE00
2026-07-1740.15PUT0 92259.65FALSE00
2026-07-1750PUT0 0200.53FALSE00
2026-07-1760PUT0 0216.54FALSE00
2026-07-1770.2PUT6 091.92FALSE0.20
2026-07-1780.5PUT41 11147.03FALSE0.50
2026-07-1790.85PUT0 675.93TRUE00
2026-07-17101.62PUT0 1474.61TRUE00
2026-07-17110PUT0 070.45TRUE00
2026-07-17120PUT0 00TRUE00
2026-07-17130PUT0 00TRUE00
2026-07-17140PUT0 00TRUE00
2026-07-17150PUT0 00TRUE00
2026-07-17167.7PUT0 10TRUE00
2026-07-17178.15PUT0 00TRUE00
2026-09-1810CALL0 0326.57TRUE00
2026-09-1820CALL0 0211.93TRUE00
2026-09-1830CALL0 1110.66TRUE00
2026-09-1845.2CALL0 11114.93TRUE00
2026-09-1850CALL0 2298.69TRUE00
2026-09-1862.7CALL0 1090.89TRUE00
2026-09-1870CALL0 112690.74TRUE00
2026-09-1881.9CALL0 21584.18TRUE00
2026-09-1891.15CALL160 67874.54FALSE-0.25-0.18
2026-09-18100.9CALL2 174176.21FALSE0.90
2026-09-18110.7CALL2 11967.44FALSE00
2026-09-18120.5CALL10 123870.42FALSE0.50
2026-09-18130.45CALL0 46768.48FALSE00
2026-09-18140.26CALL0 21271.72FALSE00
2026-09-18150.4CALL0 12175.93FALSE00
2026-09-18160CALL0 0118.7FALSE00
2026-09-18170CALL0 0118.21FALSE00
2026-09-18180CALL0 0123.87FALSE00
2026-09-1810PUT0 0498.38FALSE00
2026-09-1820PUT0 0326.49FALSE00
2026-09-1830PUT0 0268.37FALSE00
2026-09-1840PUT0 0181.86FALSE00
2026-09-1850PUT0 3141.13FALSE00
2026-09-1860.42PUT0 43687.25FALSE00
2026-09-1870.5PUT0 102071.42FALSE00
2026-09-1880.85PUT0 62249.45FALSE00
2026-09-1891.34PUT0 3748.15TRUE00
2026-09-18102PUT0 50966.06TRUE00
2026-09-18110PUT0 3048.62TRUE00
2026-09-18120PUT0 049.39TRUE00
2026-09-18130PUT0 00TRUE00
2026-09-18140PUT0 00TRUE00
2026-09-18150PUT0 00TRUE00
2026-09-18160PUT0 00TRUE00
2026-09-18170PUT0 00TRUE00
2026-09-18189.25PUT0 00TRUE00
2026-12-1810CALL0 0256.81TRUE00
2026-12-1820CALL0 00TRUE00
2026-12-1830CALL0 0125.5TRUE00
2026-12-1840CALL0 6104.46TRUE00
2026-12-1850CALL0 086.8TRUE00
2026-12-1860CALL0 092.3TRUE00
2026-12-1870CALL0 083.74TRUE00
2026-12-1882.15CALL0 585.55TRUE00
2026-12-1891.4CALL1 483.94FALSE1.40
2026-12-18101.03CALL0 4269.99FALSE00
2026-12-18110.75CALL0 4570.61FALSE00
2026-12-18120.75CALL3 365.84FALSE0.750
2026-12-18130.7CALL0 172.03FALSE00
2026-12-18140.43CALL0 488.27FALSE00
2026-12-18150CALL0 076.97FALSE00
2026-12-18160.6CALL0 466.68FALSE00
2026-12-18170CALL0 092.73FALSE00
2026-12-1810PUT0 0370.26FALSE00
2026-12-1820PUT0 0225.32FALSE00
2026-12-1830PUT0 0164.77FALSE00
2026-12-1840PUT0 0104.48FALSE00
2026-12-1850PUT0 097.98FALSE00
2026-12-1860.25PUT0 198.85FALSE00
2026-12-1870.65PUT0 176.57FALSE00
2026-12-1881.1PUT0 1267.97FALSE00
2026-12-1890PUT0 267.09TRUE00
2026-12-18100PUT0 069.84TRUE00
2026-12-18110PUT0 065.73TRUE00
2026-12-18120PUT0 052.09TRUE00
2026-12-18130PUT0 046.43TRUE00
2026-12-18140PUT0 00TRUE00
2026-12-18150PUT0 00TRUE00
2026-12-18160PUT0 00TRUE00
2026-12-18178.05PUT0 10TRUE00
2027-01-1536.14CALL0 21560.27TRUE00
2027-01-1554.02CALL1 133280.53TRUE4.020
2027-01-1560CALL0 2070.26TRUE00
2027-01-1572.62CALL3 368066.27TRUE2.620
2027-01-1581.9CALL0 8177.66TRUE00
2027-01-1592.01CALL0 17472.52FALSE00
2027-01-15101.4CALL49 913267.08FALSE0.10.08
2027-01-15110CALL0 067.72FALSE00
2027-01-15120.8CALL0 123575.03FALSE00
2027-01-15130.51CALL0 275.3FALSE00
2027-01-15150.25CALL0 115969.54FALSE00
2027-01-15170.25CALL0 28961.35FALSE00
2027-01-15200.2CALL0 93767.23FALSE00
2027-01-1530PUT0 15143.29FALSE00
2027-01-1550PUT0 13979.29FALSE00
2027-01-1560.5PUT1 1463.09FALSE0.50
2027-01-1570.7PUT0 20160.37FALSE00
2027-01-1581.11PUT0 951.93FALSE00
2027-01-1591.52PUT0 161.43TRUE00
2027-01-15102.4PUT0 106155.71TRUE00
2027-01-15110PUT0 051.34TRUE00
2027-01-15120PUT0 11066.86TRUE00
2027-01-15130PUT0 053.87TRUE00
2027-01-15150PUT0 159.01TRUE00
2027-01-15170PUT0 00TRUE00
2027-01-15200PUT0 00TRUE00
2027-03-1930CALL0 066.99TRUE00
2027-03-1950CALL0 074.79TRUE00
2027-03-1973.8CALL0 299.16TRUE00
2027-03-19100CALL0 074.37FALSE00
2027-03-19122CALL0 5082.43FALSE00
2027-03-19150CALL0 090.38FALSE00
2027-03-19170CALL0 069.02FALSE00
2027-03-1930PUT0 0185.9FALSE00
2027-03-1950PUT0 0116.06FALSE00
2027-03-1971.1PUT0 185.09FALSE00
2027-03-19100PUT0 066.9TRUE00
2027-03-19120PUT0 066.68TRUE00
2027-03-19150PUT0 054.26TRUE00
2027-03-19170PUT0 00TRUE00
2027-04-1630CALL0 096.08TRUE00
2027-04-1654.4CALL0 264.2TRUE00
2027-04-1673.4CALL0 1459.57TRUE00
2027-04-16101.8CALL0 32089.98FALSE00
2027-04-16120.95CALL0 162.7FALSE00
2027-04-16151CALL0 571.99FALSE00
2027-04-16170CALL0 096.82FALSE00
2027-04-1630PUT0 0177.94FALSE00
2027-04-1650PUT0 0113.93FALSE00
2027-04-1670.8PUT0 185.56FALSE00
2027-04-16100PUT0 050.14TRUE00
2027-04-16120PUT0 057.61TRUE00
2027-04-16150PUT0 00TRUE00
2027-04-16170PUT0 00TRUE00
2028-01-2130CALL0 3773.13TRUE00
2028-01-2155.2CALL0 43100.08TRUE00
2028-01-2173.29CALL0 41095.57TRUE00
2028-01-21103.8CALL3 54871.48FALSE3.80
2028-01-21122CALL0 17164.66FALSE00
2028-01-21151.4CALL0 9963.09FALSE00
2028-01-21170CALL0 097.99FALSE00
2028-01-2130PUT0 0148.79FALSE00
2028-01-2150PUT0 060.42FALSE00
2028-01-2170PUT0 092.32FALSE00
2028-01-21102.9PUT0 71452.58TRUE00
2028-01-21120PUT0 051.51TRUE00
2028-01-21150PUT0 056.48TRUE00
2028-01-21170PUT0 048.05TRUE00

Latest BCRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST62$9.355
Jun 13, 2022 7:59 PM EST55$9.355
Jun 13, 2022 7:59 PM EST25$9.355
Jun 13, 2022 7:59 PM EST10$9.355
Jun 13, 2022 7:59 PM EST1$9.355

BioCryst Pharmaceuticals, Inc (BCRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2020-04-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/882796/000000000020003589/0000000000-20-003589-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000021545719003209/0000215457-19-003209-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000083423720004615/0000834237-20-004615-index.htm
2019-11-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914019000618/0000899140-19-000618-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914020000183/0000899140-20-000183-index.htm
2020-04-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000090266420001843/0000902664-20-001843-index.htm
2019-01-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093041319000073/0000930413-19-000073-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093247119004892/0000932471-19-004892-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465919008702/0001104659-19-008702-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920018856/0001104659-20-018856-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021757/0001104659-20-021757-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021905/0001104659-20-021905-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037163/0001127602-18-037163-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037166/0001127602-18-037166-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037170/0001127602-18-037170-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037173/0001127602-18-037173-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037177/0001127602-18-037177-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037182/0001127602-18-037182-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000701/0001127602-19-000701-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000710/0001127602-19-000710-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000720/0001127602-19-000720-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000730/0001127602-19-000730-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000736/0001127602-19-000736-index.htm
2019-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001579/0001127602-19-001579-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001582/0001127602-19-001582-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020298/0001127602-19-020298-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020302/0001127602-19-020302-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020306/0001127602-19-020306-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020310/0001127602-19-020310-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020312/0001127602-19-020312-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020314/0001127602-19-020314-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023817/0001127602-19-023817-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023901/0001127602-19-023901-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2019-09-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029010/0001127602-19-029010-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029012/0001127602-19-029012-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035542/0001127602-19-035542-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035544/0001127602-19-035544-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035547/0001127602-19-035547-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035549/0001127602-19-035549-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035551/0001127602-19-035551-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035553/0001127602-19-035553-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035849/0001127602-19-035849-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035852/0001127602-19-035852-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001879/0001127602-20-001879-index.htm
2020-01-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001981/0001127602-20-001981-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006477/0001127602-20-006477-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006488/0001127602-20-006488-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006497/0001127602-20-006497-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006501/0001127602-20-006501-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006505/0001127602-20-006505-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006508/0001127602-20-006508-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007615/0001127602-20-007615-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007625/0001127602-20-007625-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007640/0001127602-20-007640-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007672/0001127602-20-007672-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007677/0001127602-20-007677-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007687/0001127602-20-007687-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-03-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009104/0001127602-20-009104-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009112/0001127602-20-009112-index.htm
2020-04-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220013457/0001127602-20-013457-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220015179/0001127602-20-015179-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016548/0001127602-20-016548-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016559/0001127602-20-016559-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016565/0001127602-20-016565-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016569/0001127602-20-016569-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016571/0001127602-20-016571-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016575/0001127602-20-016575-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016580/0001127602-20-016580-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016584/0001127602-20-016584-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016759/0001127602-20-016759-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2019-11-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020338/0001140361-19-020338-index.htm
2019-11-14424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020642/0001140361-19-020642-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020752/0001140361-19-020752-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020989/0001140361-19-020989-index.htm
2019-11-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119021082/0001140361-19-021082-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119021088/0001140361-19-021088-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/882796/000114036120009639/0001140361-20-009639-index.htm
2020-05-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120010641/0001140361-20-010641-index.htm
2020-05-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120011394/0001140361-20-011394-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012557/0001140361-20-012557-index.htm
2020-05-29424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012652/0001140361-20-012652-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036120012787/0001140361-20-012787-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013520/0001140361-20-013520-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013521/0001140361-20-013521-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013522/0001140361-20-013522-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419007217/0001144204-19-007217-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419008282/0001144204-19-008282-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000006/0001171843-19-000006-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000126/0001171843-19-000126-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000749/0001171843-19-000749-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001171/0001171843-19-001171-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001442/0001171843-19-001442-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184319001727/0001171843-19-001727-index.htm
2019-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002458/0001171843-19-002458-index.htm
2019-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184319002459/0001171843-19-002459-index.htm
2019-04-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002720/0001171843-19-002720-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003094/0001171843-19-003094-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319003220/0001171843-19-003220-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003529/0001171843-19-003529-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003812/0001171843-19-003812-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319003816/0001171843-19-003816-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004220/0001171843-19-004220-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004257/0001171843-19-004257-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004259/0001171843-19-004259-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005182/0001171843-19-005182-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319005326/0001171843-19-005326-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005941/0001171843-19-005941-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006063/0001171843-19-006063-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006137/0001171843-19-006137-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006859/0001171843-19-006859-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007064/0001171843-19-007064-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007155/0001171843-19-007155-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007214/0001171843-19-007214-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007363/0001171843-19-007363-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319007384/0001171843-19-007384-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319008053/0001171843-19-008053-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000183/0001171843-20-000183-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000241/0001171843-20-000241-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000650/0001171843-20-000650-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001018/0001171843-20-001018-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001229/0001171843-20-001229-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001491/0001171843-20-001491-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001492/0001171843-20-001492-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001589/0001171843-20-001589-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184320001710/0001171843-20-001710-index.htm
2020-03-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320001853/0001171843-20-001853-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002124/0001171843-20-002124-index.htm
2020-03-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320002184/0001171843-20-002184-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184320002185/0001171843-20-002185-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002295/0001171843-20-002295-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002530/0001171843-20-002530-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003357/0001171843-20-003357-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320003557/0001171843-20-003557-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003680/0001171843-20-003680-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005453/0001171843-20-005453-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005596/0001171843-20-005596-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320005753/0001171843-20-005753-index.htm
2020-08-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184320005862/0001171843-20-005862-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006161/0001171843-20-006161-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006178/0001171843-20-006178-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006249/0001171843-20-006249-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006729/0001171843-20-006729-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320007628/0001171843-20-007628-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320007740/0001171843-20-007740-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000117266120000839/0001172661-20-000839-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380519000192/0001193805-19-000192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380520000190/0001193805-20-000190-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417319000036/0001274173-19-000036-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417320000008/0001274173-20-000008-index.htm
2019-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924419000051/0001319244-19-000051-index.htm
2020-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924420000014/0001319244-20-000014-index.htm
2020-05-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/882796/999999999520001159/9999999995-20-001159-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999718009595/9999999997-18-009595-index.htm
2020-05-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999720002395/9999999997-20-002395-index.htm

BioCryst Pharmaceuticals, Inc (BCRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioCryst Pharmaceuticals, Inc (BCRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 85%
Institutional Ownership: 7395%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.0118,020.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.1118,220.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-14Lynne PowellSenior VP - CCOSell954.009.208,776.800.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-16Lynne PowellSenior VP - CCOSell3,046.009.2728,236.420.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-18Lynne PowellSenior VP - CCOSell2,000.009.4018,800.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-25Lynne PowellSenior VP - CCOSell6,000.009.6057,600.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell4,000.009.8839,520.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell2,000.009.9119,820.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01THERESA HEGGIEDirectorBuy1,666.003.004,998.0010,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2019-11-18Alane P BarnesSenior VP, Chief Legal OfficerBuy20,000.001.4529,000.00102,061.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2020-06-01THERESA HEGGIEDirectorBuy1,112.004.504,998.4411,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-08-31THERESA HEGGIEDirectorBuy1,204.004.154,996.6012,408.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2019-05-17THOMAS R II STAABSenior Vice President and CFOSell2,500.007.4518,625.00125,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOSell7,250.007.7255,970.00127,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy19,686.001.2023,623.20127,786.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOSell5,000.009.8549,250.00128,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOSell7,250.007.9257,420.00130,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy12,188.001.2014,625.60132,272.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOSell7,500.008.8166,075.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOSell7,750.007.3056,575.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOSell9,000.007.7569,750.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOSell9,750.007.6374,392.50132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOSell9,750.007.7675,660.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOSell4,500.007.6234,290.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOBuy5,000.005.4527,250.00133,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00134,926.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOBuy4,500.001.426,390.00137,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00137,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOBuy7,500.005.5141,325.00140,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOBuy7,750.005.5142,702.50140,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOBuy9,000.005.5149,590.00141,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-11-18KENNETH B JR LEEDirectorBuy5,000.001.457,250.0015,252.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-18Yarlagadda S BabuSenior VP - Drug DiscoveryBuy25,000.001.4536,250.00155,587.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-09-01THERESA HEGGIEDirectorBuy1,672.002.994,999.281,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2018-12-10Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-18Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-03-12STEVE ASELAGEDirectorBuy2,000.008.3016,600.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-11-18STEVE ASELAGEDirectorBuy15,000.001.4521,750.0021,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-12-01STEVE ASELAGEDirectorBuy1,754.002.854,998.9023,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2020-03-01STEVE ASELAGEDirectorBuy1,666.003.004,998.0025,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-06-01STEVE ASELAGEDirectorBuy1,112.004.504,998.4426,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2018-12-18William P SheridanSenior VP - CMOSell20,488.007.58155,299.042,725.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2019-09-01ROBERT ALEXANDER INGRAMDirectorBuy6,270.002.9918,747.3028,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2020-08-31STEVE ASELAGEDirectorBuy2,409.004.159,997.3528,613.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2019-01-16Lynne PowellSenior VP - CCOBuy3,046.003.229,808.123,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy4,000.003.2212,880.004,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-09-01Nancy J HutsonDirectorBuy3,344.002.999,998.5643,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-11-18Megan SniecinskiChief Business OfficerBuy45,000.001.4565,250.0045,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-18ROBERT ALEXANDER INGRAMDirectorBuy20,000.001.4529,000.0048,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-05-22STEVE ASELAGEDirectorBuy3,000.003.5710,710.005,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-11-18Nancy J HutsonDirectorBuy10,000.001.4514,500.0053,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2020-08-11Anthony DoyleChief Financial OfficerBuy54,000.004.08220,320.0054,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2019-12-01ROBERT ALEXANDER INGRAMDirectorBuy6,578.002.8518,747.3054,666.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-01Nancy J HutsonDirectorBuy3,508.002.859,997.8056,554.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2020-03-01Nancy J HutsonDirectorBuy3,333.003.009,999.0059,887.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2019-01-25Lynne PowellSenior VP - CCOBuy6,000.003.2219,320.006,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01ROBERT ALEXANDER INGRAMDirectorBuy6,250.003.0018,750.0060,916.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-06-01Nancy J HutsonDirectorBuy2,224.004.509,996.8862,111.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-08-31Nancy J HutsonDirectorBuy1,204.004.154,996.6063,315.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2020-06-01ROBERT ALEXANDER INGRAMDirectorBuy4,171.004.5018,748.6565,087.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2019-09-01STEVE ASELAGEDirectorBuy1,672.002.994,999.286,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-11-18THERESA HEGGIEDirectorBuy5,000.001.457,250.006,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2020-08-31ROBERT ALEXANDER INGRAMDirectorBuy4,518.004.1518,749.7069,605.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2019-11-18Jon P StonehousePresident & CEOBuy50,000.001.4572,500.00778,086.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-01THERESA HEGGIEDirectorBuy1,754.002.854,998.908,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-01-14Lynne PowellSenior VP - CCOBuy954.003.223,071.88954.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm